{"protocolSection":{"identificationModule":{"nctId":"NCT00073476","orgStudyIdInfo":{"id":"A1611005"},"organization":{"fullName":"Pfizer","class":"INDUSTRY"},"briefTitle":"A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke","officialTitle":"A Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a 72-Hour Infusion of CP-101,606 in Subjects With Acute Ischemic Stroke."},"statusModule":{"statusVerifiedDate":"2006-06","overallStatus":"TERMINATED","startDateStruct":{"date":"2003-09"},"completionDateStruct":{"date":"2005-02"},"studyFirstSubmitDate":"2003-11-21","studyFirstSubmitQcDate":"2003-11-21","studyFirstPostDateStruct":{"date":"2003-11-24","type":"ESTIMATED"},"lastUpdateSubmitDate":"2006-06-20","lastUpdatePostDateStruct":{"date":"2006-06-22","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"leadSponsor":{"name":"Pfizer","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke."},"conditionsModule":{"conditions":["Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE"}},"enrollmentInfo":{"count":300}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"traxiprodil (CP-101,606)"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"No or minimal neurological deficit at last visit"},{"measure":"Marked neurological improvement at last visit"}],"secondaryOutcomes":[{"measure":"Modified Rankin scale at last visit"},{"measure":"Mortality"},{"measure":"Safety assessments"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nMales \\& females age 40-90 years\n\nEnrolled in study within 6 hours of onset of stroke symptoms\n\nWilling to sign informed consent form\n\nNo significant disabilities prior to stroke\n\nExclusion Criteria:\n\nTreatment with t-PA (tissue plasminogen activator)\n\nPremorbid modified rankin scale score of 2 or more","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Pfizer CT.gov Call Center","affiliation":"Pfizer","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Pfizer Investigational Site","city":"La Mesa","state":"California","zip":"91942","country":"United States","geoPoint":{"lat":32.76783,"lon":-117.02308}},{"facility":"Pfizer Investigational Site","city":"Atlanta","state":"Georgia","zip":"30342","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Pfizer Investigational Site","city":"Fort Wayne","state":"Indiana","zip":"46804","country":"United States","geoPoint":{"lat":41.1306,"lon":-85.12886}},{"facility":"Pfizer Investigational Site","city":"Fort Wayne","state":"Indiana","zip":"46805","country":"United States","geoPoint":{"lat":41.1306,"lon":-85.12886}},{"facility":"Pfizer Investigational Site","city":"Louisville,","state":"Kentucky","zip":"40202","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"Pfizer Investigational Site","city":"Louisville","state":"Kentucky","zip":"40202","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"Pfizer Investigational Site","city":"Salisbury","state":"North Carolina","zip":"28144","country":"United States","geoPoint":{"lat":35.67097,"lon":-80.47423}},{"facility":"Pfizer Investigational Site","city":"Dayton","state":"Ohio","zip":"45406","country":"United States","geoPoint":{"lat":39.75895,"lon":-84.19161}},{"facility":"Pfizer Investigational Site","city":"Dayton","state":"Ohio","zip":"45408","country":"United States","geoPoint":{"lat":39.75895,"lon":-84.19161}},{"facility":"Pfizer Investigational Site","city":"Dayton","state":"Ohio","zip":"45409","country":"United States","geoPoint":{"lat":39.75895,"lon":-84.19161}},{"facility":"Pfizer Investigational Site","city":"Dayton","state":"Ohio","zip":"45415","country":"United States","geoPoint":{"lat":39.75895,"lon":-84.19161}},{"facility":"Pfizer Investigational Site","city":"Allentown","state":"Pennsylvania","zip":"18103","country":"United States","geoPoint":{"lat":40.60843,"lon":-75.49018}},{"facility":"Pfizer Investigational Site","city":"Philadelphia","state":"Pennsylvania","zip":"19141","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}},{"facility":"Pfizer Investigational Site","city":"Tartu","zip":"51014","country":"Estonia","geoPoint":{"lat":58.38062,"lon":26.72509}},{"facility":"Pfizer Investigational Site","city":"Bad Neustadt","zip":"97616","country":"Germany"},{"facility":"Pfizer Investigational Site","city":"Freiburg","zip":"79106","country":"Germany","geoPoint":{"lat":47.9959,"lon":7.85222}},{"facility":"Pfizer Investigational Site","city":"Leipzig","zip":"04103","country":"Germany","geoPoint":{"lat":51.33962,"lon":12.37129}},{"facility":"Pfizer Investigational Site","city":"Luebeck","zip":"23538","country":"Germany","geoPoint":{"lat":53.86893,"lon":10.68729}},{"facility":"Pfizer Investigational Site","city":"Budapest","zip":"H-1021","country":"Hungary","geoPoint":{"lat":47.49801,"lon":19.03991}},{"facility":"Pfizer Investigational Site","city":"Gyor","zip":"H-9023","country":"Hungary","geoPoint":{"lat":47.68333,"lon":17.63512}},{"facility":"Pfizer Investigational Site","city":"Pavia","zip":"27100","country":"Italy","geoPoint":{"lat":45.19205,"lon":9.15917}},{"facility":"Pfizer Investigational Site","city":"Perugia","zip":"06126","country":"Italy","geoPoint":{"lat":43.1122,"lon":12.38878}},{"facility":"Pfizer Investigational Site","city":"Coimbra","zip":"Codex 3049","country":"Portugal","geoPoint":{"lat":40.20564,"lon":-8.41955}},{"facility":"Pfizer Investigational Site","city":"Lisboa","zip":"1600","country":"Portugal","geoPoint":{"lat":38.71667,"lon":-9.13333}},{"facility":"Pfizer Investigational Site","city":"Singapore","zip":"169608","country":"Singapore","geoPoint":{"lat":1.28967,"lon":103.85007}},{"facility":"Pfizer Investigational Site","city":"Singapore","zip":"308433","country":"Singapore","geoPoint":{"lat":1.28967,"lon":103.85007}},{"facility":"Pfizer Investigational Site","city":"Santiago de Compostela","state":"Galicia","zip":"15706","country":"Spain","geoPoint":{"lat":42.88052,"lon":-8.54569}},{"facility":"Pfizer Investigational Site","city":"Madrid","zip":"28007","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Pfizer Investigational Site","city":"Madrid","zip":"28034","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Pfizer Investigational Site","city":"Zaragoza","zip":"50009","country":"Spain","geoPoint":{"lat":41.65606,"lon":-0.87734}}]},"referencesModule":{"seeAlsoLinks":[{"label":"To obtain contact information for a study center near you, click here.","url":"https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1611005&StudyName=A+Study+to+Evaluate+the+Efficacy+and+Safety+of++CP%2D101%2C606+in+Subjects+With+an+Acute+Stroke+"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}